HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiara De Ciucis Selected Research

Buthionine Sulfoximine

2/2011PKCδ sensitizes neuroblastoma cells to L-buthionine-sulfoximine and etoposide inducing reactive oxygen species overproduction and DNA damage.
1/2008GSH loss per se does not affect neuroblastoma survival and is not genotoxic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiara De Ciucis Research Topics

Disease

6Neoplasms (Cancer)
09/2020 - 01/2007
6Neuroblastoma
09/2020 - 01/2007
1Atherosclerotic Plaque (Atheroma)
01/2016
1Carcinogenesis
02/2011

Drug/Important Bio-Agent (IBA)

3Glutathione (Reduced Glutathione)IBA
10/2016 - 01/2008
3AntioxidantsIBA
10/2016 - 02/2008
2Etoposide (VP 16)FDA LinkGeneric
10/2016 - 02/2011
2Pharmaceutical PreparationsIBA
10/2016 - 02/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2011 - 02/2008
2Buthionine SulfoximineIBA
02/2011 - 01/2008
1Angiogenesis InhibitorsIBA
09/2020
1Urea (Carbamide)FDA LinkGeneric
09/2020
1Biological ProductsIBA
09/2020
13-hydroxy-5-estrane-17-carbonitrile (ACN)IBA
09/2020
127-hydroxycholesterolIBA
01/2016
1OxysterolsIBA
01/2016
1Protein Kinase CIBA
02/2011
1Intracellular Signaling Peptides and ProteinsIBA
02/2011
1buthionineIBA
02/2008
1rottlerinIBA
02/2008
1Complex MixturesIBA
01/2007

Therapy/Procedure

4Therapeutics
02/2011 - 01/2007
2Drug Therapy (Chemotherapy)
02/2011 - 02/2011